Automates procurement, invoicing, and payments to streamline supply chain operations.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Transcarent is a health technology company that aims to simplify access to high-quality, affordable healthcare for individuals and organizations. Founded to address the complexities of the healthcare system, Transcarent provides a comprehensive platform that combines benefits navigation, clinical guidance, and care delivery.
Transcarent Funding
Sign up to gain insights into Transcarent funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Mar 07, 2024 | 126M | ||
| Series C | Jan 27, 2022 | 9M | ||
| Series C | Jan 11, 2022 | 200M | ||
| Series B | Jun 10, 2021 | 58M | ||
| Series A | Nov 19, 2020 | 46M | ||
| Series Seed | Jun 17, 2020 | 3M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Transcarent Management Team
Investors
Intermountain Healthcare Innovation Fund
GreatPoint Ventures
Ally Bridge Group
Leaps by Bayer
Kleiner Perkins Caufield & Byers
Human Capital
General Catalyst
Merck Global Health Innovation Fund
Alta Partners
Threshold Ventures
7wire Ventures
Kinnevik
Jove Equity Partners
Transcarent Valuations & Financials
View real-time NPM data on Transcarent stock including daily Transcarent stock price estimates, valuation history, and historical share price information. Access Transcarent financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Transcarent pricing across six independent market signals. Looking for private company due diligence data sources on Transcarent? Get in touch to learn more.
Similar Companies
like Transcarent
FAQ
We have answers
Transcarent stock does not trade on public stock exchanges. Transcarent stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Transcarent stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Transcarent Stock does not trade on public stock exchanges. In order to sell Transcarent shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Transcarent does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Transcarent share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Transcarent stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Transcarent stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Transcarent stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Transcarent is a private company and has not had an IPO. There is currently no Transcarent IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Transcarent IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
